Highlights and Quick Summary
- Beginning Cash for the quarter ending March 31, 2023 was $48.6 Million (a Infinity% increase compared to previous quarter)
- Year-over-year quarterly Beginning Cash increased by Infinity%
- Annual Beginning Cash for 2022 was $43.3 Million (a -17.05% decrease from previous year)
- Annual Beginning Cash for 2021 was $52.3 Million (a -23.65% decrease from previous year)
- Annual Beginning Cash for 2020 was $68.4 Million (a -37.89% decrease from previous year)
- Twelve month Beginning Cash ending March 31, 2023 was $48.6 Million (a 12.12% increase compared to previous quarter)
- Twelve month trailing Beginning Cash increased by 12.12% year-over-year
Trailing Beginning Cash for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| $48.6 Million | $43.3 Million | $43.3 Million | $43.3 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Beginning Cash of Precigen, Inc.
Most recent Beginning Cashof PGEN including historical data for past 10 years.Interactive Chart of Beginning Cash of Precigen, Inc.
Precigen, Inc. Beginning Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $48.6 | – | – | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $43.34 | $43.34 |
| 2021 | $0.0 | $0.0 | $0.0 | $52.25 | $52.25 |
| 2020 | $0.0 | $0.0 | $0.0 | $68.43 | $68.43 |
| 2019 | $0.0 | $0.0 | $0.0 | $110.18 | $110.18 |
| 2018 | $0.0 | $0.0 | $0.0 | $75.55 | $75.55 |
| 2017 | $0.0 | $0.0 | $0.0 | $69.59 | $69.59 |
| 2016 | $0.0 | $0.0 | $0.0 | $135.78 | $135.78 |
| 2015 | $0.0 | $0.0 | $0.0 | $27.47 | $27.47 |
| 2014 | $0.0 | $0.0 | $0.0 | $49.51 | $49.51 |
| 2013 | $0.0 | $0.0 | $0.0 | $10.4 | $10.4 |
| 2012 | $-0.01 | $0.0 | $19.63 | – | $19.63 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology